Endometriosis: Clinical Experience of 500 Patients from India
Abstract
Background/Purpose of Study: Endometriosis, a common, chronic, gynecological condition, has a burden of around 176 million women globally and ~26 million women alone in India. It is associated with chronic pelvic pain, subfertility, dysmenorrhea and dyspareunia. Information about clinical phenotype of endometriosis is lacking in India. Additionally, the correlation between the symptoms and different characteristics of endometriosis has not been estimated in the Indian population yet. In the present study, we aimed to investigate the clinical phenotype of women with endometriosis and to describe the unusual cases of endometriosis.
Methods: Clinical phenotype of endometriosis was studied in a total of 500 women with endometriosis.
Results: Out of 500 cases, 87 (15%) of endometriosis cases were classified as Peritoneal, 291 (58%) as ovarian and 122 (24%) were having deep infiltrating endometriosis (DIE/RV). The disease was classified into Stage I-II (n=183) and Stage III-IV (n=317) as per the revised American Society for Reproductive Medicine (rASRM). In the cohort of women with endometriosis, 77% women experienced dysmenorrhea, 23% dyspareunia, 34% chronic pelvic pain and 14% suffered from dyschezia. Around 13% women had family history of endometriosis. Sixty six percent women either had primary or secondary infertility and 33% had history of miscarriage. We also detected endometriosis having unusual presentation such as endometriosis associated endometrioid
type of ovarian cancer, cervical endometriosis, endometriosis associated with didelphys uterus.
Conclusion: The incidence of endometriosis is rising in India and hence there is a need to develop uniform guidelines for the diagnosis and management of endometriosis.
References
2. Cullen TS. Philadelphia: W.B. Saunders Co; 1908. Adenomyoma of the Uterus.
3. Leng JH, Lang JH, Dai Y, Dai Y, Li HJ, Li XY. Relationship between pain symptoms and clinico-pathological features of pelvic endometriosis. Zhonghua Fu Chan KeZaZhi.2007;
42:165-68.
4. Bulletti C, Coccia M E, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet.2010; 27:441-47.
5. European Endometriosis Alliance Endometriosis April 2006: www.endometriosis.org.
6. Nnoaham K, Hummelshoj L, Webster P, D’Hooghe T, De CiccoNardone F, De CiccoNardone C, Jenkinson C, Kennedy SH, Zondervan KT. World Endometriosis Research Foundation Global Study of Women’s Health consortium. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. FertilSteril.2011; 96:366-73.
7. Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T, Falcone T, Graham B, Halis G, Horne A, Kanj O, Kjer JJ, Kristensen J, Lebovic D, Mueller M, Vigano P, Wullschleger M, D’Hooghe T. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012; 27:1292-99.
8. Brawn J, Morotti M, Zondervan KT, Becker CM, Vincent. Central changes associated with chronic pelvic pain and endometriosis. HumReprod Update.2014; 20:737-47.
9. Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. FertilSteril. 2006; 86:1561-72.
10. Gajbhiye R, Khole V. Endometriosis research in India: current scenario and challenges for future. Endo Insight. 2013; 2:4-8
11. Eskenazi B, Warner ML. Epidemiology of endometriosis. ObstetGynecol North Am. 1997; 24: 235-58.
12. Missmer S, Hankinson S, Spiegelman D, Barbieri R, Marshall LM, Hunter D. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric and lifestyle
factors. Am J Epidemiol. 2004; 160: 784-96.
13. Endometriosis Society of India. 2007: www.endosocind.org
14. Gajbhiye R, Suryawanshi A, Khan S, Meherji P, Warty N, Raut V, Chehna N, Khole V. Multiple endometrial antigens are targeted in autoimmune endometriosis. Reproductive BioMedicine Online.2008; 16:817-24.
15. Gajbhiye R, Sonawani A, Khan S, Suryawanshi A, Kadam S, Warty N, Raut V, Khole V. Identification and validation of novel serum markers for early diagnosis of endometriosis. Hum Reprod.2012; 27: 408-17.
16. Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. HumReprod Update. 2005;11:595-606.
17. Chopin N, Ballester M, Borghese B, Fauconnier A, Foulot H, Malartic C, Chapron C. Relation between severity of dysmenorrhea and endometrioma.ActaObstetGynecol Scand. 2006;85:1375-80.
18. Ballard K1, Lane H, Hudelist G, Banerjee S, Wright J. Can specific pain symptoms help in the diagnosis of endometriosis? A cohort study of women with chronic pelvic pain.
FertilSteril. 2010; 94:20-7.
19. Chapron C, Santulli P, de Ziegler D, Noel JC, Anaf V, Streuli I, Foulot H, Souza C, Borghese B. Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis.
Hum Reprod. 2012;27:702-11.
20. ASRM. American Society for Reproductive Medicine, 1997. Revised American Society for Reproductive Medicine Classification of endometriosis: 1996. FertilSteril. 67, 817- 821.
21. Falconer H. Pregnancy outcome in women with endometriosis. SeminReprod Med. 2013; 31:178-82.
22. Vercellini P, Parazzini F, Pietropaolo G, Cipriani S, Frattaruolo MP, Fedele L. Pregnancy outcome in women with peritoneal, ovarian and rectovaginal endometriosis: a retrospective cohort study. BJOG 2012; 119:1538-43.
23. Anaf V, Simon P, El Nakadi I, Fayt I, Buxant F, Simonart T, Peny MO, Noel JC. Relationship between endometriotic foci and nerves in rectovaginalendometriotic nodules. Hum Reprod. 2000;15:1744-50.
24. Laganà AS, Salmeri FM, Retto G, Sturlese E, Pizzo A, De Dominici R, Sofo V. Stage-related changes of peritoneal soluble TNFα and TNFR1 and TNFR2 in cells recovered from peritoneal fluid of women with endometriosis. J ReprodImmunol. 2012; 94: 94-95.
25. Kashima K, Ishimaru T, Okamura H, Suginami H, Ikuma K, Murakami T, Iwashita M, Tanaka K.Familial risk among Japanese patients with endometriosis.IntJGynaecol Obstet. 2004; 84:61-4.
26. Chan WY, Dawood MY, Fuchs F.Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives. Am J Med. 1981 Mar; 70:535-41.
27. Matalliotakis IM, Arici A, Cakmak H, Goumenou AG, Koumantakis G, Mahutte NG. Familial aggregation of endometriosis in the Yale Series. Arch Gynecol Obstet. 2008;278:507-11.
28. Koot YEM, Boomsma CM, Eijkemans MJC, Lentjes EGW, Macklon NS. Recurrent pre-clinical pregnancy loss is unlikely to be a ‘cause’ of unexplained infertility. Hum Reprod. 2011; 26: 2636-41.
29. Benagiano G, Farris M, Grudzinskas G. the fate of fertilized human oocytes. ReprodBioMed Online. 2010; 21:732-41.
30. Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the “black box”of real pregnancy loss. Hum Reprod Update. 2002; 8:333-43
31. Rai R, Regan L. recurrent miscarriage. Lancet. 2006; 368:601- 11.
32. Seidman JD. Prognostic importance of hyperplasia and atypia in endometiosis. Int J GynecolPathol. 1996; 15:1–9.
33. Swiersz LM. Role of endometriosis in cancer and tumor development. Ann NY Acad Sci. 2002; 955:281–92.
34. Kim H S, Kim T H, Chung H H, Song Y S. Risk and prognosis of ovarian cancer in women with endometriosis: a metaanalysis. BJC. 2014; 110:1878-90.
35. Sanfilippo JS, Wakim NG, Schikler KN, Yussman MA.Endometriosis in association with uterine anomaly.Am J Obstet Gynecol. 1986;154:39-43.
36. Yang CC, Tseng JY, Chen P, Wang PH.Uterus didelphys with cervical agenesis associated with adenomyosis, a leiomyoma and ovarian endometriosis. A case report.J Reprod Med. 2002; 47:936-8.
37. Ata B, Ates U, Usta T, Attar E.Cervical endometriosis, a case presenting with intractable spotting.MedGenMed. 2005;7:64.
